MAINTAINING REMISSION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS WHILE TAPERING ETANERCEPT: AN INSIGHT IN THE TAPERA TRIAL

被引:1
|
作者
Bertrand, Delphine [1 ]
Mannaerts, Julie [1 ]
Badot, Valerie [2 ]
Corluy, Luk [3 ]
De Cock, Diederik [1 ]
De Knop, Kathleen [4 ]
de Wergifosse, Isabelle [5 ]
Geens, Elke [6 ]
Hoffman, Ilse [4 ]
Joly, Johan [5 ]
Langenaken, Christine [3 ]
Lenaerts, Jan [3 ]
Lenaerts, Joris [5 ]
Pazmino, Sofia [1 ]
Stouten, Veerle [1 ]
Taelman, Veerle [7 ]
Walschot, Mark [5 ]
Westhovens, Rene [1 ,5 ]
Verschueren, Patrick [1 ,5 ]
机构
[1] Katholieke Univ Leuven, Skeletal Biol & Engn Res Ctr, Leuven, Belgium
[2] ULB Hop Erasme, Brussels, Belgium
[3] Reuma Inst, Hasselt, Belgium
[4] GZA Sint Augustinus, Antwerp, Belgium
[5] UZ Leuven, Rheumatol, Leuven, Belgium
[6] ZNA Jan Palfijn, Antwerp, Belgium
[7] Heilig Hart Ziekenhuis, Leuven, Belgium
关键词
D O I
10.1136/annrheumdis-2019-eular.3055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0135
引用
收藏
页码:1137 / 1137
页数:1
相关论文
共 50 条
  • [41] Predictors of Biological Antirheumatic Drug Discontinuation in Patients with Rheumatoid Arthritis while in Remission
    Kawada, Tomoyuki
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06)
  • [42] The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
    Yoshiya Tanaka
    Josef S. Smolen
    Heather Jones
    Annette Szumski
    Lisa Marshall
    Paul Emery
    Arthritis Research & Therapy, 21
  • [43] DMARD-free Remission in Established Rheumatoid Arthritis: 2 Year Results of the TARA Trial
    van Mulligen, Elise
    Weel, Angelique
    Kuijper, T. Martijn
    Hazes, J. Mieke
    van der Helm-van Mil, Annette
    de Jong, Pascal
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [44] Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial
    Sanmarti, Raimon
    Veale, Douglas J.
    Martin-Mola, Emilio
    Escudero-Contreras, Alejandro
    Gonzalez, Carlos
    Ercole, Liliana
    Alonso, Rocio
    Fonseca, Joao E.
    Alcaniz, Cristina
    Maria Alvaro-Gracia, Jose
    Balsa, Alejandro
    Luis de Pablos, Jose
    Diaz Miguel, Consuelo
    Manuel Rodriguez, Jose
    Alves, Jose
    Aurrecoechea, Elena
    Calvo, Jaime
    Belzunegui, Joaquin
    Blanco, Francisco
    Caliz, Rafael
    Calvo, Javier
    Roman Ivorra, Jose
    Canhao, Helena
    Santos, Helena
    Chamizo, Eugenio
    del Pino, Javier
    Delgado, Concepcion
    Diaz, Cesar
    Fernandez Nebro, Antonio
    Fraser, Alexander
    Gomez, Antonio
    Hernandez, Blanca
    Navarro, Federico
    Pov-Marras, Juan
    Moreno, Juan
    Perez Venegas, Jose
    Pombo, Manuel
    Riera, Elena
    Rosas, Antonio
    Ryan, John
    Santos, Jose
    Santos, Maria
    Tornero, Jesus
    Victor Tovar, Juan
    Ucar, Eduardo
    Vasconcelos, Carlos
    Veiga, Raul
    Vela, Paloma
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (10) : 1616 - 1625
  • [45] Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
    Smolen, Josef S.
    Szumski, Annette
    Koenig, Andrew S.
    Jones, Thomas V.
    Marshall, Lisa
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [46] Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
    Josef S. Smolen
    Annette Szumski
    Andrew S. Koenig
    Thomas V. Jones
    Lisa Marshall
    Arthritis Research & Therapy, 20
  • [47] Etanercept (Enbrel®) in patients with rheumatoid arthritis with recent onset versus established disease:: Improvement in disability
    Baumgartner, SW
    Fleischmann, RM
    Moreland, LW
    Schiff, MH
    Markenson, J
    Whitmore, JB
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (08) : 1532 - 1537
  • [48] IMAGING PROGRESSION DESPITE CLINICAL REMISSION IN EARLY RHEUMATOID ARTHRITIS PATIENTS AFTER ETANERCEPT INTERRUPTION
    Lagana, B.
    Diamanti, A. Picchianti
    Ferlito, C.
    Germano, V.
    Migliore, A.
    Cremona, A.
    Argento, G.
    David, V.
    Salemi, S.
    D'Amelio, R.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (02) : 447 - 454
  • [49] Contributions of Social Determinants of Health on Probability of Remission in Early and Established Rheumatoid Arthritis Patients
    Cui, Kangping
    Bombardier, Claire
    Tomlinson, George A.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [50] Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis
    van der Heijde, D.
    Klareskog, L.
    Landewe, R.
    Bruyn, G. A. W.
    Cantagrel, A.
    Durez, P.
    Herrero-Beaumont, G.
    Molad, Y.
    Codreanu, C.
    Valentini, G.
    Zahora, R.
    Pedersen, R.
    MacPeek, D.
    Wajdula, J.
    Fatenejad, S.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 3928 - 3939